App-Quantinova.ai

Control of Oral Advanced Glycation Endproducts (AGEs) By Sevelamer Carbonate Improves Glucose Metabolism and Albuminuria in Stage 2-4 Diabetic Kidney Disease (DKD)

Gary E Striker - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic nephropathy

Sevelamer carbonate

Dapagliflozin Reduces HbA1c and Systolic Blood Pressure in Patients with Type 2 Diabetes: Subgroup Analysis Based on Patient Characteristics

Michael A Weber - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Dapagliflozin

Glycemic Control of Patients with Type 2 Diabetes in Korea: The Fifth Korea National Health and Nutrition Examination Survey (KNHANES V)

Ja Young Jeon - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Fibrocalculous Pancreatic Diabetes Is Characterized By Insulin Resistance and Impaired Insulin Secretion

Riddhi Das Gupta - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Use of Long Acting Somatostatin Analog (Lanreotide) in Children with Congenital Hyperinsulinism

Pratik Shah - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Familial hyperinsulinemic hypoglycemia

Lanreotide

The Role of IGF1/IGFBP3 System in Pre-Diabetes and New-Onset Diabetes Diagnosed with Different Criteria

Ilhan Satman - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Diagnosis of Prediabetes: Comparison the Concurrent Results of OGTT, HbA1c and CGMS

Mehmet Sargin - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Relationship Between Circulating Betatrophin Levels and Insulin Resistance in Prediabetic Subjects

Mehmet Calan - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

betatrophin

Alternative Tritation Algorithm for the Initiation of Basal Insulin for Unskilled Patients and Health Providers: A Initiative for the Real Wealth Limited World

Carlos Dominguez-Reyes - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Insulin glargine

Physiologic Factors Predicting Glycemic Control Among Patients with Longstanding Type 2 Diabetes on Insulin Therapy

Lynn Kessler - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Amtolmetin guacil

Effect of PPAR-?2 Gene Pro12Ala Polymorphism (rs1801282), Vitamin D3 and BMI in Type 2 Diabetic Subjects; Its Association with Hemoglobin A1c Level: A Study on 902 Subjects from Western India

Jayesh J Sheth - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

cholecalciferol

Hormonal-Metabolic Status of Postmenopausal Females Carrying Single-Nucleotide Polymorphisms Associated or Not Associated with Potential Response to Metformin

Lev M Berstein - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Type 2 diabetes mellitus

Alora

Circulating Soluble CD14 and Its Relation to Serum Cytokines in Type 2 Diabetes Mellitus

Seth Weaver - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Insulinoma in a Type 2 Diabetic

Foiqa Chaudhry - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

sulfonylureas

Management of Insulin Autoimmune Syndrome in a Non-Asian Male: Use of Immunosuppression, Continuous Glucose Monitoring, and Serial Antibody Titers

David R Saxon - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hepatitis C

Amoclan suspension

Prolonged and Unexplained Reactive Hypoglycemia in a Caucasian Male: An Unusual Case of Hirata Disease

Daniel E. Okorodudu - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

sulfonylureas

Steroids Curing Hyperglycemia in a Case of Chronic Autoimmune Pancreatitis

Ruchita Patel - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Repaglinide

The Association of Serum Fibroblast Growth Factor 21 with Insulin Secretory Function and Metabolic Parameters in Type 2 Diabetes

Hye Soon Kim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

FGF-21

A Novel HNF1B Mutation and Its Associated Clinical Presentation

Marconi Abreu - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Maturity onset diabetes of the young

sulfonylureas

Cognitive Dysfunction and Gestational Diabetes Mellitus

Fatma Ela Keskin - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Filters

4759 Abstracts